Articles

MDoutlook® Delivers Precision Intelligence

php
After every major conference, MDOutlook provides valuable insights on the impact of new data presented. In our 2nd OncoPoll™ study following the 2019 ASCO conference, we researched what US and EU5 oncologists thought about a number of new agents being developed that target specific driver mutations in small populations of
Read more
php
After every major conference, MDOutlook provides valuable insights on the impact of new data presented. At the 2019 ASCO conference, prostate cancer was one of the hottest areas, and our 1st independent OncoPoll™ study researched how clinicians will be treating the non-metastatic castration-resistant and the metastatic hormone-sensitive prostate cancer (nmCRPC
Read more
php
Identifying the right expert at the right time is often a challenge for many life sciences companies and their agencies. What if there would be a short-cut (with no compromises!) to gain precision engagement with ThoughtLeaders and related treaters? At MDOutlook, we help you tap into the expertise of over
Read more
php
With the deluge of scientific data presentations at a conference, it is very competitive for life science companies to break through the noise and assess impact. By evaluating whether announcements change oncologists’ behavior, we can estimate how a data presentation influences their future treatment decisions and clinical practice. Clients often
Read more
php
After every major conference, MDOutlook provides valuable insights on the impact of new data presented. In our 2nd OncoPoll™ study following the 2019 ASCO conference, we researched what US and EU5 oncologists thought about a number of new agents being developed that target specific driver mutations in small populations of
Read more
php
After every major conference, MDOutlook provides valuable insights on the impact of new data presented. At the 2019 ASCO conference, prostate cancer was one of the hottest areas, and our 1st independent OncoPoll™ study researched how clinicians will be treating the non-metastatic castration-resistant and the metastatic hormone-sensitive prostate cancer (nmCRPC
Read more
php
Identifying the right expert at the right time is often a challenge for many life sciences companies and their agencies. What if there would be a short-cut (with no compromises!) to gain precision engagement with ThoughtLeaders and related treaters? At MDOutlook, we help you tap into the expertise of over
Read more
php
With the deluge of scientific data presentations at a conference, it is very competitive for life science companies to break through the noise and assess impact. By evaluating whether announcements change oncologists’ behavior, we can estimate how a data presentation influences their future treatment decisions and clinical practice. Clients often
Read more
php
After every major conference, MDOutlook provides valuable insights on the impact of new data presented. In our 2nd OncoPoll™ study following the 2019 ASCO conference, we researched what US and EU5 oncologists thought about a number of new agents being developed that target specific driver mutations in small populations of
Read more
php
After every major conference, MDOutlook provides valuable insights on the impact of new data presented. At the 2019 ASCO conference, prostate cancer was one of the hottest areas, and our 1st independent OncoPoll™ study researched how clinicians will be treating the non-metastatic castration-resistant and the metastatic hormone-sensitive prostate cancer (nmCRPC
Read more
php
Identifying the right expert at the right time is often a challenge for many life sciences companies and their agencies. What if there would be a short-cut (with no compromises!) to gain precision engagement with ThoughtLeaders and related treaters? At MDOutlook, we help you tap into the expertise of over
Read more
php
With the deluge of scientific data presentations at a conference, it is very competitive for life science companies to break through the noise and assess impact. By evaluating whether announcements change oncologists’ behavior, we can estimate how a data presentation influences their future treatment decisions and clinical practice. Clients often
Read more
Three Ways to Identify and Activate ThoughtLeaders

3 Ways To Identify And Activate ThoughtLeaders Webinar

In this webinar, we will help you (1) go deeper in identifying your ThoughtLeaders in a specific disease area, (2) to target your ThoughtLeaders for the right type of activity and (3) provide you the foundation for building stronger relationships with specific ThoughtLeaders and their influence networks.

Read More »
Webinar Cover

Performance Tracking To Stay Ahead Of The Curve On-Demand Webinar

You need brand and market insights yesterday! You are not satisfied with the insights provided because each time you receive them, they are out of date. You want to stay one step ahead. In this webinar, we share ways that you can stay ahead by reacting in time through informed confident business decisions.

Read More »

Archives

[archives type=monthly limit=10]

Links

FDA Drug information:
http://www.fda.gov/Drugs

European Medicines Agency:
http://www.ema.europa.eu/

Publication Research:
http://www.ncbi.nlm.nih.gov/pubmed

Clinical Trials Research:
http://www.clinicaltrials.gov/